Instil Bio, Inc. (TIL)
7.15
+0.01
(+0.14%)
USD |
NASDAQ |
Sep 30, 16:00
7.15
0.00 (0.00%)
After-Hours: 18:42
Instil Bio Price to Book Value : 0.4516 for Sept. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 0.451 |
| September 28, 2026 | 0.4446 |
| September 25, 2026 | 0.4528 |
| September 24, 2026 | 0.4497 |
| September 23, 2026 | 0.457 |
| September 22, 2026 | 0.4503 |
| September 21, 2026 | 0.4465 |
| September 18, 2026 | 0.4478 |
| September 17, 2026 | 0.4554 |
| September 16, 2026 | 0.4535 |
| September 15, 2026 | 0.4554 |
| September 14, 2026 | 0.4705 |
| September 11, 2026 | 0.4661 |
| September 10, 2026 | 0.4648 |
| September 09, 2026 | 0.4787 |
| September 08, 2026 | 0.4939 |
| September 04, 2026 | 0.4787 |
| September 03, 2026 | 0.4838 |
| September 02, 2026 | 0.4854 |
| September 01, 2026 | 0.4857 |
| August 31, 2026 | 0.4806 |
| August 28, 2026 | 0.4787 |
| August 27, 2026 | 0.4964 |
| August 26, 2026 | 0.4945 |
| August 25, 2026 | 0.48 |
| Date | Value |
|---|---|
| August 24, 2026 | 0.4933 |
| August 21, 2026 | 0.4787 |
| August 20, 2026 | 0.4693 |
| August 19, 2026 | 0.4667 |
| August 18, 2026 | 0.4617 |
| August 17, 2026 | 0.4648 |
| August 14, 2026 | 0.4661 |
| August 13, 2026 | 0.4592 |
| August 12, 2026 | 0.4724 |
| August 11, 2026 | 0.4731 |
| August 10, 2026 | 0.468 |
| August 07, 2026 | 0.468 |
| August 06, 2026 | 0.4598 |
| August 05, 2026 | 0.4585 |
| August 04, 2026 | 0.4579 |
| August 03, 2026 | 0.456 |
| July 31, 2026 | 0.4497 |
| July 30, 2026 | 0.451 |
| July 29, 2026 | 0.456 |
| July 28, 2026 | 0.4604 |
| July 27, 2026 | 0.4516 |
| July 24, 2026 | 0.4503 |
| July 23, 2026 | 0.4547 |
| July 22, 2026 | 0.4579 |
| July 21, 2026 | 0.4579 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.653 |
| Alnylam Pharmaceuticals, Inc. | 24.38 |
| Anika Therapeutics, Inc. | 1.917 |
| Savara, Inc. | 7.363 |
| Vericel Corp. | 5.547 |
Price to Book Value Related Metrics
| Price | 7.15 |
| Earnings Yield | -62.55% |
| Market Cap | 48.49M |